Pharmaceuticals Archives

Pharmaceuticals

Human-Based Drug Testing Revolutionizes Pharma

Mini-organs, smart chips, and AI are revolutionizing drug development. This shift away from traditional animal testing promises more effective, efficient, and humane treatments, driven by scientific breakthroughs and landmark legislation.

LNGFRM Team

07/31/2025
- BiotechnologyPharmaceuticals

Three animal silhouettes – a rat, a rabbit, and a large hoofed animal – rendered with a pixelated pattern on a red and grey gradient background.

Biotechnology

Human-Based Drug Testing Revolutionizes Pharma

LNGFRM Team

Biotechnology

Human-Based Drug Testing Revolutionizes Pharma

LNGFRM Team

The AI Revolution in Pharmaceuticals

LNGFRM Team

Biomedical Engineering

Strategic Alliance Advances Production of Promising Cancer Therapy Terbium-161

LNGFRM Team

Biotechnology

Shanghai CirCode Biomed’s HM2002 Receives FDA Clearance as First Circular RNA Drug for Ischemic Heart Disease

LNGFRM Team

Biotechnology

FDA Approves Avenzo Therapeutics’ Investigational Cancer Treatment AVZO-1418/DB-1418 for Clinical Trials

LNGFRM Team

"Audience seated in a conference room facing a large display screen showing a detailed view of a high-tech data server. Attendees are engaged with some using their phones to capture the presentation."

Pharmaceuticals

Quantum Computing: A Game Changer in Drug Development

LNGFRM Team

"Abstract illustration featuring two scientists in white lab coats working at desks, set against a vibrant yellow background. A large DNA double helix and stylized molecular structures are portrayed in the scene."

Biotechnology

OBI Pharma Receives FDA Approval for Phase I/II Trial of Innovative Cancer Treatment OBI-902

LNGFRM Team

"An abstract illustration featuring an eye at the center, surrounded by a gavel, a newspaper, and wavy patterns, all set against a colorful background of orange and blue tones."

Biotechnology

Kodiak Sciences Unveils Innovative Ocular Therapies at ARVO 2025 Annual Meeting

LNGFRM Team

Breakthroughs

Amgen’s UPLIZNA: A Breakthrough Therapy for IgG4-Related Disease

LNGFRM Team

Biotechnology

FDA Announces Phase-Out of Animal Testing in Drug Development, Embracing New Technologies

LNGFRM Team

AI-Driven Collaboration Transforms Drug Discovery with New Screening Libraries

LNGFRM Team

Medical Devices

FDA Leads Healthcare Innovation with New Treatments and Safety Measures

LNGFRM Team